Indivior Q4 earnings beat; SUBLOCADE rev $252M (+30%); new $400M buyback; FY26 guidance reaffirmed

Indivior Pharmaceuticals, Inc.

2025-FY EPS reported $1.64 revenue$1,239,000,000

Q4 total net revenue $358M (+20% YoY); SUBLOCADE net revenue $252M (+30%); GAAP diluted EPS $0.79 vs $0.17
Non-GAAP Q4 net income $107M ($0.82 diluted EPS); Adjusted EBITDA $142M (+91% YoY)
FY 2025: revenue $1,239M (+4%), SUBLOCADE $856M (+13%); GAAP net income $210M ($1.64 EPS); adj. EBITDA $428M (+20%)
Board authorized new $400M share repurchase program (up to 18 months) for opportunistic deployment
FY 2026 guidance: SUBLOCADE $905M-$945M, adj. EBITDA $535M-$575M, non-GAAP opex $430M-$450M

item 2.02 item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-26-073363
form_type: 8-K
ticker: INDV
cik: 0001625297
company_name: Indivior Pharmaceuticals, Inc.
filed_at: 2026-02-26T23:59:59+00:00
discovered_at: 2026-05-14T18:02:35.673919+00:00
generated_at: 2026-05-15T23:37:37.738758+00:00
sec_items: ["2.02", "7.01", "9.01"]
event_type: earnings
sentiment: positive
materiality_score: 0.85
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-26-073363
json_url: https://secwatch.observer/filing/0001193125-26-073363.json
markdown_url: https://secwatch.observer/filing/0001193125-26-073363.md
text_url: https://secwatch.observer/filing/0001193125-26-073363.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1625297/000119312526073363/0001193125-26-073363-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1625297/000119312526073363/d713689d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-26-073363

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.